Norges Bank’s Ra Pharmaceuticals, Inc. Common Stock RARX Stock Holding History

Norges Bank’s Portfolio RARX Stock Details RARX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-200,000	Closed	-$9.6M	–	2115
2020 Q1	$9.6M	Buy	+200,000	New	+$9.3M	﹤0.01%	1635
2017 Q1	–	Sell	-20,000	Closed	-$304K	–	2209
2016 Q4	$304K	Buy	+20,000	New	+$272K	﹤0.01%	2131

Other funds holding RARX

Daiwa Securities Group Tokyo, Japan $34.8B AUM 20.7% 1-Year Est. Return

Norges Bank's RARX Position: Q2 2020 in Review

Norges Bank sold out of Ra Pharmaceuticals, Inc. Common Stock (RARX) in Q2 2020, closing a stake of 200,000 shares — an estimated $9.6M sold.

Norges Bank first reported a position in RARX in Q4 2016 and held it in 2 quarters. The position peaked at $9.6M in Q1 2020. 1 fund tracked by Wall St. Rank holds RARX as of Q2 2020.

Norges Bank reported no remaining Ra Pharmaceuticals, Inc. Common Stock position as of Q2 2020 after selling out during the quarter.
Norges Bank sold 200,000 Ra Pharmaceuticals, Inc. Common Stock shares in Q2 2020, an estimated $9.6M.
Norges Bank first reported a position in Ra Pharmaceuticals, Inc. Common Stock in Q4 2016 and held it in 2 quarters.
Norges Bank's Ra Pharmaceuticals, Inc. Common Stock position peaked at $9.6M in Q1 2020.
1 fund tracked by Wall St. Rank held Ra Pharmaceuticals, Inc. Common Stock as of Q2 2020.

Based on Norges Bank's 13F filing for Q2 2020, filed 7 Aug 2020.